Abstract
Gastric exclusion has been introduced as a surgical treatment for morbid obesity. We describe two women who had undergone gastric bypass for obesity with metabolic bone disease and secondaryhyperparathyroidism. In one patient transiliac bone biopsy after double tetracycline labelling demonstrated histologic evidence of hyperparathyroidism with osteitis fibrosa cystica. Six additional women who had undergone gastric exclusion were evaluated. Serum phosphorus, calcium, and creatinine were normal in all but one patient who had hypocalcemia. Serum immunoreactive parathyroid hormone was elevated in seven of eight patients and urinary calcium was ≤2 mmol/d (80 mg/24 h) in 6 patients. Lumbar spine bone mineral density was 86±7 (mean±SE) per cent of predicted and femoral neck bone mineral density was 89±6 per cent of predicted. Women who have had gastric exclusion for obesity may develop secondary hyperparathyroidism which could result in loss of bone mass.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Griffen WO. Gastric bypass. In: Griffen WO, Printen KH, eds. Surgical management of morbid obesity. New York: Marcel Dekker, 1987: 27–45.
Mason EE. Gastroplasty. In: Griffen WO, Printen KJ, eds. Surgical management of morbid obesity. New York: Marcel Dekker, 1987: 47–69.
Halverson JD, Teitelbaum SL, Haddad JG, Murphy WA. Skeletal abnormalities after jejunoileal bypass. Ann Surg 1979; 189: 785–90.
Parfitt AM, Miller MJ, Frame B et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978; 89: 193–9.
Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol 1984; 79: 850–60.
Mazess RB, Barden HS, Ettinger M et al. Spine and femur density using dual-photon absorptiometry in US white women. Bone Miner 1987; 2: 211–9.
Hahn TJ. Bone complications of anticonvulsants. Drugs 1976; 12: 201–11.
Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984; 58: 1003–9.
Krolner B, Ranlov PJ, Clemmesen TH, Pors Nielsen S. Bone loss after gastroplasty for morbid obesity: side-effect or adaptive response to weight reduction (letter). Lancet 1982; i: 956–7.
Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg 1986; 52: 594–8.
Halverson JD, Zuckerman GR, Koehler RE, Gentry K, Michael HEB, Deschryver-Kecskemeti K. Gastric bypass for morbid obesity; a medical-surgical assessment. Ann Surg 1981; 194: 152–60.
Nilas L, Christiansen C, Christiansen J. Regulation of vitamin D and calcium metabolism after gastrectomy. Gut 1985; 26: 252–7.
Bordier PH, Matrajt H, Hioco D, Hepner GW, Thompson GR, Booth CC. Subclinical vitamin D deficiency following gastric surgery; histologic evidence in bone. Lancet 1968; i: 437–40.
Morgan DB, Hunt G, Paterson CR. The osteomalacia syndrome after stomach operations. Q J Med 1970; 39: 395–410.
Garrick R, Ireland AW, Posen S. Bone abnormalities after gastric surgery; a prospective histologic study. Ann Intern Med 1971; 75: 221–5.
Thompson GR, Lewis B, Booth CC. Vitamin D absorption after partial gastrectomy. Lancet 1966; i: 457–8.
Eddy RL. Metabolic bone disease after gastrectomy. Am J Med 1971; 50: 442–9.
Klein KB, Orwoll ES, Lieberman DA, Meier DE, McClung MR, Parfitt AM. Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. Gastrenterology 1987; 92: 608–16.
Andersen T, Larsen U. Dietary outcome in obese patients treated with a gastroplasty program. Am J Clin Nutr 1989; 50: 1328–40.
Young EA, Taylor MM, Taylor MK, McFee AS, Miller OL, Gleiser CA. Gastric stapling for morbid obesity: gastrointestinal response in a rat model. Am J Clin Nutr 1984; 40: 293–302.
Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 1984; 73: 640–7.
Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985; 313: 70–3.
Stewart A, Broadus A. Mineral metabolism. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and Metabolism, 2nd edn. New York: McGraw-Hill; 1987: 1351.
Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987; 325: 62–5.
Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370–3.
Steiniche T, Vesterby A, Eriksen EF, Mosekilde L, Melson F. A histomorphometric determination of iliac bone structure and remodelling in obese subjects. Bone 1986; 7: 77–82.
Liel Y, Edwards J, Shary J, Spicer KM, Gordon L, Bell NH. The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab 1988; 66: 1247–50.
Myers D, Gage D. ‘I lost 125 pounds’. Good Housekeeping 1988; 206(5): 82–5.
Author information
Authors and Affiliations
Additional information
Deceased
Rights and permissions
About this article
Cite this article
Shaker, J.L., Norton, A.J., Woods, M.F. et al. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporosis Int 1, 177–181 (1991). https://doi.org/10.1007/BF01625450
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01625450